Difference between revisions of "Equine Encephalitis Virus"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
{{unfinished}} | {{unfinished}} | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
====Antigenicity==== | ====Antigenicity==== | ||
| Line 36: | Line 27: | ||
*Human vaccination recommended for vets in endemic areas | *Human vaccination recommended for vets in endemic areas | ||
[[Category:Togaviridae]] | [[Category:Togaviridae]] | ||
| + | [[Category:Horse]] | ||
Revision as of 13:58, 21 May 2010
 |
This article is still under construction. |
Antigenicity
- 3 Serotypes identified:
- Eastern EEV
- Western EEV
- Venezuelan EEV
Pathogenesis
- Viremia
- CNS replication within a week, causing:
- Paralysis of the lips
- Drooping eyelids
- Incoordination
- Often fatal
Epidemiology
- Transfer via vector: mostly through mosquito salivary transfer
Diagnosis
- Clinical signs
- Virus isolation can be performed from blood or spinal fluid
Control
- Annual vaccination
- Vector control
- Human vaccination recommended for vets in endemic areas